Atlas Trials

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Clinical trial NCT00654602 · COMPLETED

Trial details

NCT number
NCT00654602
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dyslipidaemia
Start date
2002-02-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.